Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Valiant Laboratories Ltd. ( (IN:VALIANTLAB) ) is now available.
Valiant Laboratories Ltd. has announced the dispatch of letters to shareholders who have not registered their email addresses, providing them with a web-link to access the Annual Report for the Financial Year 2024-25 and the Notice of the 4th Annual General Meeting. This initiative is part of the company’s efforts to ensure transparency and compliance with SEBI regulations, enhancing communication with stakeholders and facilitating their participation in the AGM through virtual means.
More about Valiant Laboratories Ltd.
Valiant Laboratories Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of a range of pharmaceutical products. The company is committed to maintaining a strong market presence and ensuring compliance with regulatory requirements.
Average Trading Volume: 6,313
Technical Sentiment Signal: Strong Sell
Learn more about VALIANTLAB stock on TipRanks’ Stock Analysis page.